Exosome treatments are the fastest-growing category in Korean aesthetic dermatology — and also the most variable in quality and claim. Korean clinics have been using exosome-derived serums since around 2020, well ahead of most Western markets. The gap between a well-designed protocol (topical exosomes after microneedling, where the evidence is reasonable) and an oversold one (intravenous exosome infusions for “anti-ageing”) is significant. This article covers what the science actually supports.
What exosomes are
Exosomes are extracellular vesicles, roughly 30–150 nanometres in diameter, released by most cell types. In aesthetic medicine, the exosomes used in treatments are derived from mesenchymal stem cells (MSCs) or plant cells, then harvested, purified, and either freeze-dried or suspended for topical application.
Their cargo includes:
- Growth factors (VEGF, EGF, TGF-β)
- MicroRNA (mRNA that regulates cell behaviour)
- Proteins and lipids that mediate cell-to-cell signalling
When applied to skin — particularly after microneedling creates microchannels — these molecules are absorbed by keratinocytes and fibroblasts, signalling increased collagen production, reduced inflammation, and faster repair.
Products used in Korean clinics
| Product | Source cells | Format | Primary use | Price per session |
|---|---|---|---|---|
| ASCE+ (Exosome Korea) | Human adipose MSC | Lyophilised (freeze-dried); reconstituted for topical use | Post-laser/microneedling skin recovery | ₩200,000–₩500,000 |
| Exosome Skin Booster (various brands) | Human umbilical cord MSC | Topical serum; microchannel delivery | Hydration + collagen stimulation | ₩150,000–₩400,000 |
| Plant exosomes (rose, centella) | Plant cells | Topical serum; microneedling delivery | Soothing; anti-inflammatory | ₩100,000–₩250,000 |
| Scalp exosome protocol | Human MSC | Topical after scalp microneedling | Hair growth stimulation | ₩200,000–₩400,000 per session |
How exosomes are actually used in Korean clinics
The most evidence-supported application is as a post-procedure accelerant — applied topically or via microchannels immediately after:
- Microneedling / Morpheus8 / RF microneedling: Exosomes enter via the microchannels created by the treatment, increasing growth factor delivery to the dermis at exactly the point when the skin is most receptive.
- Fractional laser (CO2 or pico): Topical exosome application immediately after laser reduces recovery time and may enhance collagen stimulation.
- Scalp microneedling for hair: Applied to the scalp in the same session as microneedling or Dermaroller for androgenetic alopecia.
As a standalone topical treatment (applied to intact skin), absorption is minimal and clinical effect is correspondingly modest. The combination protocol is where Korean dermatologists see the clearest benefit.
The evidence, honestly assessed
Current evidence on exosomes for skin comes primarily from:
- In vitro (cell culture) studies — strong signal, but not the same as human skin
- Small pilot trials (20–50 patients, no control group) — promising but underpowered
- A growing number of randomised controlled trials from Korea and China (2022–2025), most showing statistically significant improvement in skin elasticity, hydration, and clinical photo scores
The honest summary: the biological rationale is solid, early human trial data is encouraging, but the level of evidence does not yet support the marketing claims made by some clinics (“reverses ageing,” “equivalent to facelift”). Exosomes are a reasonable addition to a comprehensive treatment protocol. They are not a standalone miracle.
What to avoid
- Intravenous exosome infusions: Not approved in Korea for cosmetic use, not supported by clinical evidence, and carrying unknown risks from systemic delivery of biological material. Any clinic offering IV exosome drips for skin or “whole body rejuvenation” is operating outside evidence and likely outside regulation.
- Unspecified “stem cell” treatments: Exosomes are not stem cells. A clinic conflating the two either doesn’t understand what they’re selling or is deliberately misleading you.
Are exosomes the same as stem cells?
No. Exosomes are secreted by stem cells but contain no DNA and cannot replicate. They carry messenger RNA, proteins, and lipids that communicate with surrounding cells and trigger repair responses. This is why they are considered lower regulatory risk than live stem cells — they cannot proliferate or differentiate — but it also means their effects are transient and may require repeat treatment.
Is ASCE+ safe and approved in Korea?
ASCE+ (by Exosome Korea) is approved for cosmetic use by KFDA as a topical product applied to the skin surface or via microchannel delivery. It is not approved as an injectable drug. Korean clinics that apply it after microneedling or laser are using it within its approved category. Clinics claiming to 'inject' exosomes intravenously are operating outside evidence and regulatory approval — avoid these.
Can exosome treatment help with hair loss?
Preliminary evidence is promising. Scalp-applied or microneedled exosomes in small clinical studies show improvement in hair thickness and reduced shedding, likely via Wnt pathway activation in dermal papilla cells. Korean clinics offer this as a series of 4–6 sessions. The evidence quality is still low-to-moderate; it is most rationally used alongside PRP, minoxidil, or low-level laser therapy rather than as a standalone.